$140,000 of MARVELL TECHNOLOGY INC. lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Semiconductor Policy and Programs."
You can find more data on corporate lobbying on Quiver Quantitative.
MRVL Congressional Stock Trading
Members of Congress have traded $MRVL stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $MRVL stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARIA ELVIRA SALAZAR sold up to $15,000 on 09/24.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 07/17.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
MRVL Insider Trading Activity
MRVL insiders have traded $MRVL stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $MRVL stock by insiders over the last 6 months:
- CHRIS KOOPMANS (President and COO) has made 0 purchases and 5 sales selling 50,000 shares for an estimated $10,931,000.
- MATTHEW J MURPHY (Chairman of the Board and CEO) has made 0 purchases and 6 sales selling 45,000 shares for an estimated $10,353,600.
- SANDEEP BHARATHI (President, Data Center Group) has made 0 purchases and 3 sales selling 14,929 shares for an estimated $3,328,973.
- WILLEM A MEINTJES (Chief Financial Officer) sold 4,000 shares for an estimated $700,960
- DANIEL DURN (Chief Financial Officer) sold 2,250 shares for an estimated $632,272
- JUSTIN SCARPULLA (SVP, Chief Accounting Officer) sold 1,100 shares for an estimated $300,949
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
MRVL Hedge Fund Activity
We have seen 1,359 institutional investors add shares of MRVL stock to their portfolio, and 779 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 74,322,607 shares (-56.6%) from their portfolio in Q2 2026, for an estimated $22,139,961,399
- BLACKROCK, INC. added 21,798,190 shares (+34.1%) to their portfolio in Q2 2026, for an estimated $6,493,462,819
- INVESCO LTD. added 19,762,168 shares (+187.8%) to their portfolio in Q2 2026, for an estimated $5,886,952,225
- JPMORGAN CHASE & CO added 13,891,628 shares (+inf%) to their portfolio in Q2 2026, for an estimated $4,138,177,064
- PRICE T ROWE ASSOCIATES INC /MD/ added 12,134,409 shares (+714.3%) to their portfolio in Q2 2026, for an estimated $3,614,719,097
- AMERIPRISE FINANCIAL INC removed 11,747,911 shares (-56.4%) from their portfolio in Q2 2026, for an estimated $3,499,585,207
- JANE STREET GROUP, LLC removed 8,725,263 shares (-87.7%) from their portfolio in Q2 2026, for an estimated $2,599,168,595
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
MRVL Price Targets
Multiple analysts have issued price targets for $MRVL recently. We have seen 22 analysts offer price targets for $MRVL in the last 6 months, with a median target of $272.5.
Here are some recent targets:
- Srini Pajjuri from RBC Capital set a target price of $360.0 on 07/07/2026
- C.J. Muse from Cantor Fitzgerald set a target price of $300.0 on 06/29/2026
- Timothy Arcuri from UBS set a target price of $340.0 on 06/29/2026
- Tore Svanberg from Stifel set a target price of $350.0 on 06/24/2026
- Vivek Arya from B of A Securities set a target price of $365.0 on 06/23/2026
- John Vinh from Keybanc set a target price of $385.0 on 06/18/2026
- Craig Ellis from B. Riley Securities set a target price of $345.0 on 06/12/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
